A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment

NCT02878538 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was withdrawn before IRB approval

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Deferiprone
OTHER: Placebo phase

Sponsor

The University of Texas Health Science Center at San Antonio